Patients within Niagara Health have been getting opportunities to participate in COVID-19 related clinical trials.
Some of the studies happening at Niagara Health include the REMAP-Cap Study, which is evaluating the clinical effectiveness of various COVID-19 treatments in ICU patients.
There is also the COVI-Prone Study, which is examining whether lying on the stomach for COVID-19 patients with respiratory reduces the need for medical ventilation.
Johan Viljoen, Niagara Health's Chief of Staff spoke of the importance of these trials.
"The opportunity for our patients to be part of these clinical trials is important for discovering new and effective treatments for COVID-19."
Cyclist Killed in Niagara on the Lake
Province Investing Against Invasive Species
Niagara Driver Charged with Drug Impairment
Welland Man Arrested for Child Porn
28 More Doctors Hired in Niagara
Killed Police Officers Honoured by NRP
Niagara Wineries Shuttle Service Possible
Canal Days Vendors Warned of Scams